Cissy Houston, Whitney Houston's mother and Grammy winner, dies at age 91
Cissy Houston performed alongside superstar musicians like Elvis Presley and Aretha Franklin.
Watch CBS News
Cissy Houston performed alongside superstar musicians like Elvis Presley and Aretha Franklin.
Dr. Ali Rezai told 60 Minutes that new developments in blood testing could help doctors identify patients who are at risk for Alzheimer's disease.
American neurosurgeon Ali Rezai is pioneering ways to try to help people with drug addiction and with Alzheimer's disease. One experiment focuses beams of ultrasound on the brain.
The number of people living with dementia is expected to triple by the year 2050 to 153 million people as the global population ages. Now a new report highlights the risk factors for dementia that if addressed early in life could prevent or delay millions of cases. CBS News' Michael George has more.
A new study highlights new risk factors for dementia, as well as 12 previously known risk factors, and ways to combat them.
FDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.
The FDA on Tuesday approved a new medication for people in the early stages of Alzheimer's disease. Dr. Jon LaPook explains what the drug is meant to do and explores its limitations.
Scientists studying a Colombian family plagued by early-in-life Alzheimer's have found a rare gene variant that seems to delay initial symptoms by about five years.
New experimental treatments using ultrasound energy to target the brain are being tested to help people with Alzheimer's and those battling drug addiction. The pioneering neurosurgeon behind the technology spoke with 60 Minutes.
This Sunday, Sharyn Alfonsi reports on a groundbreaking approach to brain surgery that could revolutionize the treatment of Alzheimer’s disease and drug addiction without any incisions.
Bad air from wildfires or agriculture were most strongly linked to dementia risk.
Medicare could shell out more than $100,000 a year per patient to cover the drug and the complex scans and tests needed to monitor its potentially lethal risks for patients.
Do you have a family history of any physical or mental health conditions? Experts explain how genetics play a role in your potential risk levels.
"I was so sad. I couldn't sleep. I felt dead," she said. "And then I spent a lot of time with Tony. He wanted nothing but my friendship and my voice."
The 60 Minutes correspondent said of his report, "It was among the most extraordinary things I'd experienced on a shoot."
A new report in the Alzheimer's Association's Journal offers the first estimates of the prevalence of where Alzheimer's disease is most prevalent in the U.S. It determined that seniors living in the East and Southeast regions of the country are most likely to have the debilitating illness. Neurologist Dr. Dona Murphey joined CBS News to talk about the findings.
Eli Lilly's experimental Alzheimer's drug donanemab can modestly slow the worsening of the disease by about four to seven months, according to researchers.
Even with Medicare coverage, many seniors will be on the hook for a hefty co-payment for the newly approved drug.
Leqembi is not a cure, but it is the first drug shown to slow the progression of Alzheimer's disease. It first received an accelerated approval from the FDA earlier this year.
Hanna, 76, first displayed symptoms of Alzheimer's in 2017.
Drugmaker Eli Lilly says its new antibody infusion could slow cognitive decline in Alzheimer's patients.
Shares of the pharmaceutical company jumped almost 5% after announcing promising results for donanemab.
People who follow Mediterranean or MIND diets may have fewer signs of Alzheimer's disease in their brain tissue, according to a new study.
Programs assisting people with dementia — and their caregivers — improve quality of life and care. But millions of families may not know where or how to find help
Stevens died following a battle with Alzheimer's disease, her son told CBS News in a statement.